Health Sciences Acquisitions 2 Receivables

Health Sciences Acquisitions 2 (HSAQ) currently reports a receivables of $51K as of June 2026. That compares with $83K in the prior-year period — down 38.6% year over year. Use the charts on this page to explore Health Sciences Acquisitions 2's receivables history and peer comparisons.

Health Sciences Acquisitions 2's receivables decreased from $83K to $51K — a 38.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Health Sciences Acquisitions 2 reported $51K in receivables as of June 2026. That compares with $83K in the prior-year period — down 38.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $51K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Health Sciences Acquisitions 2, and consider following HSAQ for alerts when major investors trade the stock.